Wan‐Hsuan Chang

585 total citations
17 papers, 472 citations indexed

About

Wan‐Hsuan Chang is a scholar working on Molecular Biology, Materials Chemistry and Neurology. According to data from OpenAlex, Wan‐Hsuan Chang has authored 17 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Materials Chemistry and 3 papers in Neurology. Recurrent topics in Wan‐Hsuan Chang's work include Muscle Physiology and Disorders (4 papers), Nanoparticles: synthesis and applications (4 papers) and Quantum Dots Synthesis And Properties (3 papers). Wan‐Hsuan Chang is often cited by papers focused on Muscle Physiology and Disorders (4 papers), Nanoparticles: synthesis and applications (4 papers) and Quantum Dots Synthesis And Properties (3 papers). Wan‐Hsuan Chang collaborates with scholars based in Taiwan, Australia and Hungary. Wan‐Hsuan Chang's co-authors include Yi‐Ching Lo, Yu‐Ting Tseng, Pinpin Lin, Ming‐Hsien Tsai, Louis W. Chang, Mo‐Hsiung Yang, Chih‐Lung Lin, Chung‐Shi Yang, Yin‐Chih Fu and Han Chang and has published in prestigious journals such as International Journal of Molecular Sciences, British Journal of Pharmacology and European Journal of Pharmacology.

In The Last Decade

Wan‐Hsuan Chang

15 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wan‐Hsuan Chang Taiwan 11 204 151 79 57 43 17 472
Sung-Hyeuk Park South Korea 16 161 0.8× 89 0.6× 53 0.7× 59 1.0× 27 0.6× 22 535
Anjum Dihingia India 13 138 0.7× 97 0.6× 130 1.6× 40 0.7× 40 0.9× 19 596
Dinesh Devadoss United States 14 274 1.3× 172 1.1× 137 1.7× 20 0.4× 78 1.8× 28 744
Nicoleta Decea Romania 14 127 0.6× 138 0.9× 71 0.9× 16 0.3× 93 2.2× 44 652
Bohan Zhang China 11 236 1.2× 120 0.8× 137 1.7× 17 0.3× 26 0.6× 31 693
Anna Pieniążek Poland 13 168 0.8× 31 0.2× 107 1.4× 19 0.3× 22 0.5× 42 623
Y. Robert Li United States 12 204 1.0× 34 0.2× 47 0.6× 57 1.0× 41 1.0× 23 483
Chang Woo Song South Korea 12 145 0.7× 58 0.4× 37 0.5× 30 0.5× 40 0.9× 20 387
Jianghai Liu China 14 233 1.1× 123 0.8× 209 2.6× 58 1.0× 41 1.0× 36 918
Ming Ding China 9 146 0.7× 203 1.3× 29 0.4× 82 1.4× 130 3.0× 12 516

Countries citing papers authored by Wan‐Hsuan Chang

Since Specialization
Citations

This map shows the geographic impact of Wan‐Hsuan Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan‐Hsuan Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan‐Hsuan Chang more than expected).

Fields of papers citing papers by Wan‐Hsuan Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wan‐Hsuan Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan‐Hsuan Chang. The network helps show where Wan‐Hsuan Chang may publish in the future.

Co-authorship network of co-authors of Wan‐Hsuan Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Wan‐Hsuan Chang. A scholar is included among the top collaborators of Wan‐Hsuan Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan‐Hsuan Chang. Wan‐Hsuan Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Cheng, Lin, Wan‐Hsuan Chang, Hung‐Te Hsu, et al.. (2024). Spatheliachromen mitigates methylglyoxal-induced myotube atrophy by activating Nrf2, inhibiting ubiquitin-mediated protein degradation, and restoring mitochondrial function. European Journal of Pharmacology. 984. 177070–177070. 1 indexed citations
3.
Chang, Wan‐Hsuan, Hung‐Te Hsu, Chih‐Cheng Lin, et al.. (2024). Linalool, a Fragrance Compound in Plants, Protects Dopaminergic Neurons and Improves Motor Function and Skeletal Muscle Strength in Experimental Models of Parkinson’s Disease. International Journal of Molecular Sciences. 25(5). 2514–2514. 10 indexed citations
4.
Chang, Wan‐Hsuan, Yi‐Hong Tsai, Hung‐Te Hsu, et al.. (2023). Guilu Erxian Jiao enhances protein synthesis, glucose homeostasis, mitochondrial biogenesis and slow-twitch fibers in the skeletal muscle. Journal of Food and Drug Analysis. 31(1). 116–136. 1 indexed citations
5.
Chang, Wan‐Hsuan, et al.. (2023). MIMO Laptop Antenna for WiFi 6E. 96–99.
6.
Hsu, Hung‐Te, Yalan Yang, Wan‐Hsuan Chang, et al.. (2022). Hyperbaric Oxygen Therapy Improves Parkinson’s Disease by Promoting Mitochondrial Biogenesis via the SIRT-1/PGC-1α Pathway. Biomolecules. 12(5). 661–661. 29 indexed citations
7.
Lin, Chih‐Lung, Wan‐Hsuan Chang, Chih‐Hsiang Chang, et al.. (2022). Protective Effects of the Chalcone-Based Derivative AN07 on Inflammation-Associated Myotube Atrophy Induced by Lipopolysaccharide. International Journal of Molecular Sciences. 23(21). 12929–12929. 4 indexed citations
8.
Tseng, Yu‐Ting, et al.. (2021). Triptolide prevents LPS‐induced skeletal muscle atrophy via inhibiting NF‐κB/TNF‐α and regulating protein synthesis/degradation pathway. British Journal of Pharmacology. 178(15). 2998–3016. 115 indexed citations
11.
Tseng, Yu‐Ting, Wan‐Hsuan Chang, Chih‐Cheng Lin, et al.. (2018). Protective effects of Liuwei dihuang water extracts on diabetic muscle atrophy. Phytomedicine. 53. 96–106. 24 indexed citations
12.
Han, Chang, Chia‐Chi Ho, Chung Shi Yang, et al.. (2013). Involvement of MyD88 in zinc oxide nanoparticle-induced lung inflammation. Experimental and Toxicologic Pathology. 65(6). 887–896. 45 indexed citations
13.
Lin, Chia‐Hua, Louis W. Chang, Yau‐Huei Wei, et al.. (2012). Electronic microscopy evidence for mitochondria as targets for Cd/Se/Te‐based quantum dot 705 toxicity in vivo. The Kaohsiung Journal of Medical Sciences. 28(7S). S53–62. 16 indexed citations
14.
Yeh, Teng‐Kuang, Jen‐Kun Chen, Chia‐Hua Lin, et al.. (2012). Kinetics and tissue distribution of neutron-activated zinc oxide nanoparticles and zinc nitrate in mice: effects of size and particulate nature. Nanotechnology. 23(8). 85102–85102. 39 indexed citations
15.
Lin, Chia‐Hua, Mo‐Hsiung Yang, Louis W. Chang, et al.. (2010). Cd/Se/Te-based quantum dot 705 modulated redox homeostasis with hepatotoxicity in mice. Nanotoxicology. 5(4). 650–663. 48 indexed citations
16.
Yeh, Teng‐Kuang, Jui-Pin Wu, Louis W. Chang, et al.. (2010). Comparative tissue distributions of cadmium chloride and cadmium-based quantum dot 705 in mice: Safety implications and applications. Nanotoxicology. 5(1). 91–97. 20 indexed citations
17.
Lin, Chia‐Hua, Louis W. Chang, Han Chang, et al.. (2009). The chemical fate of the Cd/Se/Te-based quantum dot 705 in the biological system: toxicity implications. Nanotechnology. 20(21). 215101–215101. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026